REFERENCES

1. Keays DA, Tian G, Poirier K, et al. Mutations in alpha-tubulin cause abnormal neuronal migration in mice and lissencephaly in humans. Cell. 2007;128:45-57.

2. Aiken J, Buscaglia G, Bates EA, Moore JK. The α-tubulin gene TUBA1A in brain development: a key ingredient in the neuronal isotype blend. J Dev Biol. 2017;5:8.

3. Schröter J, Popp B, Brennenstuhl H, et al. Complementing the phenotypical spectrum of TUBA1A tubulinopathy and its role in early-onset epilepsies. Eur J Hum Genet. 2022;30:298-306.

4. Schröter J, Döring JH, Garbade SF, et al. Cross-sectional quantitative analysis of the natural history of TUBA1A and TUBB2B tubulinopathies. Genet Med. 2021;23:516-23.

5. Brar BK, Thompson MG, Vora NL, et al.; Fetal Sequencing Consortium. Prenatal phenotyping of fetal tubulinopathies: a multicenter retrospective case series. Prenat Diagn. 2022;42:1686-93.

6. Ramirez DA, Anninger WV, Scoles D. Optic nerve hypoplasia and bilateral persistent fetal vasculature due to tuba1a tubulinopathy. Retin Cases Brief Rep. 2025;19:264-6.

7. Richards S, Aziz N, Bale S, et al.; ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405-24.

8. Wilcox EH, Webb RF, Tshering KC, et al.; ClinGen RASopathy Expert Panel. Updated ACMG/AMP specifications for variant interpretation and gene curations from the ClinGen RASopathy expert panels. Genet Med Open. 2025;3:103430.

9. Tavtigian SV, Greenblatt MS, Harrison SM, et al.; ClinGen Sequence Variant Interpretation Working Group (ClinGen SVI). Modeling the ACMG/AMP variant classification guidelines as a Bayesian classification framework. Genet Med. 2018;20:1054-60.

10. Tavtigian SV, Harrison SM, Boucher KM, Biesecker LG. Fitting a naturally scaled point system to the ACMG/AMP variant classification guidelines. Hum Mutat. 2020;41:1734-7.

11. Abou Tayoun AN, Pesaran T, DiStefano MT, et al.; ClinGen Sequence Variant Interpretation Working Group (ClinGen SVI). Recommendations for interpreting the loss of function PVS1 ACMG/AMP variant criterion. Hum Mutat. 2018;39:1517-24.

12. Brandt T, Sack LM, Arjona D, et al. Adapting ACMG/AMP sequence variant classification guidelines for single-gene copy number variants. Genet Med. 2020;22:336-44.

13. Riggs ER, Andersen EF, Cherry AM, et al. Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen). Genet Med. 2020;22:245-57.

14. Belvindrah R, Natarajan K, Shabajee P, et al. Mutation of the α-tubulin Tuba1a leads to straighter microtubules and perturbs neuronal migration. J Cell Biol. 2017;216:2443-61.

15. Leca I, Phillips AW, Ushakova L, Cushion TD, Keays DA. Codon modification of Tuba1a alters mRNA levels and causes a severe neurodevelopmental phenotype in mice. Sci Rep. 2023;13:1215.

16. Hoff KJ, Aiken JE, Gutierrez MA, Franco SJ, Moore JK. TUBA1A tubulinopathy mutants disrupt neuron morphogenesis and override XMAP215/Stu2 regulation of microtubule dynamics. Elife. 2022;11:e76189.

17. Aiken J, Moore JK, Bates EA. TUBA1A mutations identified in lissencephaly patients dominantly disrupt neuronal migration and impair dynein activity. Hum Mol Genet. 2019;28:1227-43.

18. Cabet S, Karl K, Garel C, et al. Two different prenatal imaging cerebral patterns of tubulinopathy. Ultrasound Obstet Gynecol. 2021;57:493-7.

19. Hebebrand M, Hüffmeier U, Trollmann R, et al. The mutational and phenotypic spectrum of TUBA1A-associated tubulinopathy. Orphanet J Rare Dis. 2019;14:38.

20. Gardner JF, Cushion TD, Niotakis G, et al. Clinical and functional characterization of the recurrent TUBA1A p.(Arg2His) mutation. Brain Sci. 2018;8:145.

21. Yokoi S, Ishihara N, Miya F, et al. TUBA1A mutation can cause a hydranencephaly-like severe form of cortical dysgenesis. Sci Rep. 2015;5:15165.

22. Myers KA, Bello-Espinosa LE, Kherani A, Wei XC, Innes AM. TUBA1A mutation associated with eye abnormalities in addition to brain malformation. Pediatr Neurol. 2015;53:442-4.

23. Shimojima K, Narita A, Maegaki Y, Saito A, Furukawa T, Yamamoto T. Whole-exome sequencing identifies a de novo TUBA1A mutation in a patient with sporadic malformations of cortical development: a case report. BMC Res Notes. 2014;7:465.

24. Okumura A, Hayashi M, Tsurui H, et al. Lissencephaly with marked ventricular dilation, agenesis of corpus callosum, and cerebellar hypoplasia caused by TUBA1A mutation. Brain Dev. 2013;35:274-9.

25. Sohal AP, Montgomery T, Mitra D, Ramesh V. TUBA1A mutation-associated lissencephaly: case report and review of the literature. Pediatr Neurol. 2012;46:127-31.

26. Lecourtois M, Poirier K, Friocourt G, et al. Human lissencephaly with cerebellar hypoplasia due to mutations in TUBA1A: expansion of the foetal neuropathological phenotype. Acta Neuropathol. 2010;119:779-89.

27. Fallet-Bianco C, Loeuillet L, Poirier K, et al. Neuropathological phenotype of a distinct form of lissencephaly associated with mutations in TUBA1A. Brain. 2008;131:2304-20.

28. Monaghan KG, Leach NT, Pekarek D, Prasad P, Rose NC.; ACMG Professional Practice and Guidelines Committee. The use of fetal exome sequencing in prenatal diagnosis: a points to consider document of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2020;22:675-80.

29. Walsh N, Cooper A, Dockery A, O'Byrne JJ. Variant reclassification and clinical implications. J Med Genet. 2024;61:207-11.

30. Li LS, Li DZ. Ongoing reanalysis of prenatal exome sequencing data leads to higher diagnostic yield. Ultrasound Obstet Gynecol. 2022;59:833-4.

31. Jansen AC, Oostra A, Desprechins B, et al. TUBA1A mutations: from isolated lissencephaly to familial polymicrogyria. Neurology. 2011;76:988-92.

32. ClinGen Sequence Variant Interpretation Recommendation for de novo Criteria (PS2/PM6) - Version 1.1. Available from: https://www.clinicalgenome.org/site/assets/files/3461/svi_proposal_for_de_novo_criteria_v1_1.pdf. [Last accessed on 12 Mar 2026].

33. ClinGen Sequence Variant Interpretation Recommendation for PM2 - Version 1.0. Available from: https://www.clinicalgenome.org/site/assets/files/5182/pm2_-_svi_recommendation_-_approved_sept2020.pdf. [Last accessed on 12 Mar 2026].